Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-08

Clinical Trial Update: Combined THC and CBD Drops for Treatment of Crohn's Disease [Phase 1, Phase 2]

View source ↗

Summary

A combined THC and CBD drop formulation for Crohn's disease has completed Phase 1 and Phase 2 trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • THC and CBD drops

Snippet

Sponsor: Meir Medical Center | Conditions: Crohn's Disease | Phase 1, Phase 2 | Status: COMPLETED